WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007080509) SUSTAINED RELEASE COMPOSITIONS OF ALFUZOSIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/080509    International Application No.:    PCT/IB2007/000087
Publication Date: 19.07.2007 International Filing Date: 12.01.2007
IPC:
A61K 9/52 (2006.01), A61K 9/22 (2006.01)
Applicants: WOCKHARDT LTD [IN/IN]; Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051, Maharashtra (IN) (For All Designated States Except US).
KANDI, Chandrashekhar, Shriram [IN/IN]; (IN).
JAIN, Girish, Kumar [IN/IN]; (IN).
GUPTA, Amit [IN/IN]; (IN)
Inventors: KANDI, Chandrashekhar, Shriram; (IN).
JAIN, Girish, Kumar; (IN).
GUPTA, Amit; (IN)
Agent: Eswaran, K., Lyer; c/o Wockhardt Ltd, Mulund-Goregaon Link Road, Bhandup, Mumbai 400 078, Maharashtra (IN)
Priority Data:
44/MUM/06 12.01.2006 IN
45/MUM/06 12.01.2006 IN
46/MUM/06 12.01.2006 IN
1395/MUM/06 31.08.2006 IN
Title (EN) SUSTAINED RELEASE COMPOSITIONS OF ALFUZOSIN
(FR) PRÉPARATIONS À LIBÉRATION PROLONGÉE D'ALFUZOSINE
Abstract: front page image
(EN)The invention relates to sustained release compositions of alfuzosin or pharmaceutically acceptable salts thereof that include one or more functional layers. The functional layer includes alfuzosin or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable hydrophilic and/or hydrophobic rate-controlling polymers.
(FR)La présente invention concerne des préparations à libération prolongée d'alfuzosine ou de sels de qualité pharmaceutique dudit composé qui incluent une ou plusieurs couches fonctionnelles. La couche fonctionnelle inclut de l'alfuzosine ou des sels de qualité pharmaceutique dudit composé et un ou plusieurs polymères hydrophiles et/ou hydrophobes de qualité pharmaceutique pour le contrôle de la vitesse.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)